About IMI
 

Home

News

22.07.2014

We are delighted to announce that the Open PHACTS project will be extended for 18 months until the end of February 2016. For the extension two new partnersLaboratorios Almirall S.A. and SciBite Limited – will join the consortium and GlaxoSmithKline (GSK) will act as coordinator.

Read more...

02.07.2014

We are glad to announce the update of DisGeNET RDF. Please find all the new data and information related at http://rdf.disgenet.org/.


01.07.2014

Open PHACTS for Academia – 6th Community Workshop held

The sixth Open PHACTS Community Workshop was held at Burlington House, Piccadilly, London on 26th June 2014. The Workshop focussed on introducing members of the academic community to the Open PHACTS Discovery Platform, and showing them how to use it within their research and teaching workflows.

Read more...

24.06.2014

Cambridge, UK – The not-for-profit Open PHACTS Foundation announced its first three members today – GlaxoSmithKline, Janssen and Roche – who will steer the future of the successor organisation to the Innovative Medicines Initiative (IMI)-funded Open PHACTS project.

Read more...

Upcoming Events

Conferences:

  

August 10-14, 2014
248th ACS National Meeting & Exposition in San Francisco, US 

  

August 31 -  September 4, 2014
20th EuroQSAR in St. Petersburg, Russia 

 

Project Meetings:  

  

September 10, 2014
Open PHACTS SureChEMBL Planning Meeting at EBI in Cambridgeshire, UK

  

November 5-6, 2014
8th Open PHACTS Workpackage Leader & Steering Committee Meeting at AZ in Mölndal, Sweden

 

 

IMI EU EFPIA